Search
for
Sort by
Research 841–870 of 1000+
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Clinical Significance of Dense Fine Speckled Pattern in Anti-nuclear Antibody Test using Indirect Immunofluorescence Method
- Pregnancy and Skin
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Pregnancy's effects on the skin
- Postherpetic Poliosis
- Letters: CD4+ Lymphocytopenia in Systemic Lupus Erythematosus
- Alopecia as a systemic disease
- Pruritic urticarial papules and plaques of pregnancy
- Isomorphic and isotopic phenomenon occurring simultaneously in a case of granuloma annulare
- Diagnosis of stress-associated dermatologic conditions in New York City safety-net hospitals during the COVID-19 pandemic
- Social isolation: main dermatosis and the impact of stress during the COVID-19 pandemic
- Dermatology Issues in Sports
- Effects of Wet Cupping on Blood Components Specially Skin-Related Parameters of Healthy Cases: A Case Control Metabonomic Study
- [Mycophenolate mofetil in induction and maintenance therapy for juvenile onset severe lupus nephritis].
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Post Herpetic Itch Leading to Frictional Alopecia of Eyebrow and Scalp-A Hitherto Undescribed Phenomenon
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
- Cutaneous Manifestations of COVID-19
- Janus Kinase (JAK) Inhibitors in Dermatology: An Update and Critical Review
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Shared Spaces: Decoding Dual Dermatoses in a Single Dermatome
- Autologous Mini Punch Graft in Vitiligo: A Narrative Review
- A clinical study of Geriatric dermatoses at Tertiary care center in South India
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Dermatological manifestations associated with COVID‐19 and COVID‐19 vaccination: results from the Lebanese COVID registry
- Dermatological Issues Among Individuals Receiving Palliative Care - A Review
- Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice
- 512 Varicella-zoster virus in actively spreading segmental vitiligo skin